Compliance Rate
Compliance Rate
51.23%
Compliant submissions
187
Incompliant submissions
178
Total trials
365
My Organizations' Clinical Trials
Showing 2325 of 2400 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/31/02
End: 06/30/05
Due: 06/30/06
Phase: N/A
Priority: Normal
Start: 02/22/06
End: 08/17/11
Due: 08/17/12
Phase: N/A
Priority: Normal
Start: 07/22/05
End: 01/14/11
Due: 01/14/12
Phase: N/A
Priority: Normal
Start: 01/01/19
End: 11/11/19
Due: 11/11/20
Phase: N/A
Priority: Normal
Start: 01/31/08
End: 12/31/10
Due: 12/31/11
Phase: N/A
Priority: Normal
Start: 05/26/23
End: 03/31/27
Due: 03/31/28
Phase: N/A
Priority: Normal
Start: 03/16/06
End: 09/17/12
Due: 09/17/13
Phase: N/A
Priority: Normal
Start: 06/30/00
End: 07/31/07
Due: 07/31/08
Phase: N/A
Priority: Normal
Start: -
End: 05/31/08
Due: 05/31/09
Phase: N/A
Priority: Normal
Start: 01/31/09
End: 05/31/12
Due: 05/31/13
A Study of Atvogen in Healthy Volunteers and HIV-Infected Patients Who Have No Symptoms of Infection
Phase: N/A
Priority: Normal
Start: -
End: 01/31/90
Due: 01/31/91
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 10/31/02
End: 08/31/04
Due: 08/31/05
Phase: N/A
Priority: Normal
Start: 08/19/24
End: 09/06/28
Due: 09/06/29
Phase: N/A
Priority: Normal
Start: -
End: 09/30/05
Due: 09/30/06
Phase: N/A
Priority: Normal
Start: 12/31/10
End: 11/30/15
Due: 11/30/16
Phase: N/A
Priority: Normal
Start: 11/17/16
End: 10/09/18
Due: 10/09/19
Phase: N/A
Priority: Normal
Start: -
End: 11/30/97
Due: 11/30/98
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: -
End: 06/30/91
Due: 06/30/92
Phase: N/A
Priority: Normal
Start: 11/30/00
End: 08/31/05
Due: 08/31/06
Phase: N/A
Priority: Normal
Start: 03/31/05
End: 02/28/10
Due: 02/28/11
Phase: N/A
Priority: Normal
Start: 12/31/10
End: 08/31/11
Due: 08/31/12
Phase: N/A
Priority: Normal
Start: 09/03/14
End: 06/13/17
Due: 06/13/18
Phase: N/A
Priority: Normal
Start: -
End: 06/30/05
Due: 06/30/06